Literature DB >> 19258475

The association of tumor microsatellite instability phenotype with family history of colorectal cancer.

Bharati Bapat1, Noralane M Lindor, John Baron, Kim Siegmund, Lin Li, Yingye Zheng, Robert Haile, Steve Gallinger, Jeremy R Jass, Joanne P Young, Michelle Cotterchio, Mark Jenkins, John Grove, Graham Casey, Stephen N Thibodeau, D Timothy Bishop, John L Hopper, Dennis Ahnen, Polly A Newcomb, Loic Le Marchand, John D Potter, Daniela Seminara.   

Abstract

Family history is a strong predictor of colorectal cancer risk; however, a diagnosis of colorectal cancer among first-degree relatives has not been systematically investigated as a function of the colorectal cancer molecular subtypes related to tumor microsatellite instability (MSI) status. We investigated whether the observable familial colorectal cancer risks differed according to tumor MSI subtypes, stratified as MSI-High (>30% instability), MSI-Low (<30% instability), and MSS (no instability). Data from 3,143 population-based colorectal cancer cases from five institutions were assessed for family history according to the Amsterdam criteria and the Bethesda guidelines, age at diagnosis, sex, tumor location, and MSI status. The distribution of patient characteristics by MSI status was compared using polytomous logistic regression. Overall, 2.8% colorectal cancer cases met the Amsterdam criteria and 37% met the Bethesda guidelines. There were 14% MSI-High, 13% MSI-Low, and 73% MSS colorectal cancers. MSI-High (P<0.0001) and MSI-Low tumors (P=0.01) were more proximally located than MSS tumors. MSI-High tumors were more common among females (P<0.001). The highest proportion of MSI-High tumors occurred in cases<40 years of age whereas the age-dependent distribution of MSI-Low tumors was unchanged. MSI-High tumors showed a statistically significant association with increasing numbers of first-degree relatives with colorectal cancer (P=0.002); this association disappeared, however, when MSI-High cases meeting Amsterdam criteria were removed from the analysis. MSI-Low tumors did not show a similar association with family history of colorectal cancer. Familial risk associated with MSI-High tumors is primarily driven by the Amsterdam-criteria patients. MSI-Low tumors may represent a distinct subtype of colorectal cancer with respect to certain epidemiologic variables studied here.

Entities:  

Mesh:

Year:  2009        PMID: 19258475      PMCID: PMC2763617          DOI: 10.1158/1055-9965.EPI-08-0878

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  44 in total

Review 1.  Testing guidelines for hereditary non-polyposis colorectal cancer.

Authors:  Asad Umar; John I Risinger; Ernest T Hawk; J Carl Barrett
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

2.  Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age.

Authors:  Sanjay Kakar; Lawrence J Burgart; Stephen N Thibodeau; Kari G Rabe; Gloria M Petersen; Richard M Goldberg; Noralane M Lindor
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

3.  Family history of colorectal cancer as a marker of potential malignancy within a screening program.

Authors:  P Rozen; Z Fireman; A Figer; C Legum; E Ron; H T Lynch
Journal:  Cancer       Date:  1987-07-15       Impact factor: 6.860

4.  Low-level microsatellite instability in most colorectal carcinomas.

Authors:  Päivi Laiho; Virpi Launonen; Päivi Lahermo; Manel Esteller; Mingzhou Guo; James G Herman; Jukka-Pekka Mecklin; Heikki Järvinen; Pertti Sistonen; Kyoung-Mee Kim; Darryl Shibata; Richard S Houlston; Lauri A Aaltonen
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

5.  Family studies in cancer of the colon and rectum.

Authors:  E Lovett
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

6.  Familial risk for colorectal cancers are mainly due to heritable causes.

Authors:  Kari Hemminki; Bowang Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-07       Impact factor: 4.254

7.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

8.  Family incidence of carcinoma of the colon and rectum in north-east Scotland.

Authors:  J L Duncan; J Kyle
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

9.  Incidence and familial occurrence of colorectal cancer and polyps in a health-care district of northern Italy.

Authors:  M Ponz de Leon; A Antonioli; A Ascari; G Zanghieri; C Sacchetti
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

10.  Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.

Authors:  J M Cunningham; E R Christensen; D J Tester; C Y Kim; P C Roche; L J Burgart; S N Thibodeau
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

View more
  15 in total

1.  Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry.

Authors:  A Joan Levine; Aung Ko Win; Daniel D Buchanan; Mark A Jenkins; John A Baron; Joanne P Young; Tiffany I Long; Daniel J Weisenberger; Peter W Laird; Rebecca L McCall; David J Duggan; Robert W Haile
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-05

Review 2.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

3.  Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry.

Authors:  Mine S Cicek; Noralane M Lindor; Steven Gallinger; Bharati Bapat; John L Hopper; Mark A Jenkins; Joanne Young; Daniel Buchanan; Michael D Walsh; Loic Le Marchand; Terrilea Burnett; Polly A Newcomb; William M Grady; Robert W Haile; Graham Casey; Sarah J Plummer; Lisa A Krumroy; John A Baron; Stephen N Thibodeau
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

4.  Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.

Authors:  A Joan Levine; Amanda I Phipps; John A Baron; Daniel D Buchanan; Dennis J Ahnen; Stacey A Cohen; Noralane M Lindor; Polly A Newcomb; Christophe Rosty; Robert W Haile; Peter W Laird; Daniel J Weisenberger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-28       Impact factor: 4.254

5.  Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.

Authors:  Daniel J Weisenberger; A Joan Levine; Tiffany I Long; Daniel D Buchanan; Rhiannon Walters; Mark Clendenning; Christophe Rosty; Amit D Joshi; Mariana C Stern; Loic LeMarchand; Noralane M Lindor; Darshana Daftary; Steven Gallinger; Teresa Selander; Bharati Bapat; Polly A Newcomb; Peter T Campbell; Graham Casey; Dennis J Ahnen; John A Baron; Robert W Haile; John L Hopper; Joanne P Young; Peter W Laird; Kimberly D Siegmund
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-13       Impact factor: 4.254

6.  Molecular classification and precision therapy of cancer: immune checkpoint inhibitors.

Authors:  Yingyan Yu
Journal:  Front Med       Date:  2017-12-05       Impact factor: 4.592

7.  PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.

Authors:  Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Wolfram Goessling; Andrew T Chan; Kimmie Ng; Jennifer A Chan; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

8.  Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum.

Authors:  Liang Wang; Chun-Han Lo; Xiaosheng He; Dong Hang; Molin Wang; Kana Wu; Andrew T Chan; Shuji Ogino; Edward L Giovannucci; Mingyang Song
Journal:  Gastroenterology       Date:  2020-04-01       Impact factor: 22.682

9.  Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer.

Authors:  Shoko Kure; Katsuhiko Nosho; Yoshifumi Baba; Natsumi Irahara; Kaori Shima; Kimmie Ng; Jeffrey A Meyerhardt; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-29       Impact factor: 4.254

10.  p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis.

Authors:  Shuji Ogino; Katsuhiko Nosho; Kaori Shima; Yoshifumi Baba; Natsumi Irahara; Gregory J Kirkner; Aditi Hazra; Immaculata De Vivo; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.